Sansure Biotech, Inc. Financials

Market Capitalization CN¥11.83 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	46.41
Forward PE	25.85
Price to Sales TTM	CN¥8.41
Price to Book MRQ	CN¥1.62
Enterprise to Revenue	5.25
Enterprise to EBITDA	46.52

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	18.44%
Operating Margin	-6.52%
Return on Assets TTM	0.31%
Return on Equity TTM	2.88%

Income Statement

Revenue TTM	CN¥1,407,156,224
Revenue per Share TTM	CN¥2.44
Quarterly Revenue Growth	54.10%
Gross Profit TTM	CN¥1,091,663,104
EBITDA	CN¥264,297,876
Net Income to Common TTM	CN¥259,424,576
Diluted EPS TTM	CN¥0.44
Quarterly Earnings Growth YoY	-81.40%

Balance Sheet

Total Cash MRQ	CN¥4,568,799,744
Total Cash per Share MRQ	CN¥7.96
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	5.92
Current Ratio MRQ	8.04
Book Value per Share MRQ	CN¥12.62

Cash Flow

Operating Cash Flow TTM	CN¥203,140,592
Levered Free Cash Flow TTM	CN¥-162,947,120

688289 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	579,388,032
Float Shares	273,694,182
Avg 10 Volume	7,117,193
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	50.64%
% Held by Institutions	11.96%

Stock Price Summary

Beta	0.70
Fifty Two Week Low	CN¥16.08
Fifty Two Week High	CN¥25.58
Fifty Two Week Change	5.00%
Day 50 MA	CN¥22.15
Day 200 MA	CN¥19.98

Dividends and Splits

Forward Annual Dividend Rate	CN¥0.50
Forward Annual Dividend Yield	2.45%
Trailing Annual Dividend Rate	CN¥0.45
Trailing Annual Dividend Yield	2.20%
Payout Ratio	161.86%
Dividend Date
Ex Dividend Date	2024-09-26
Last Split Factor
Last Split Date	2022-06-01